BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that it closed a previously announced sale to affiliates of its largest shareholder, Sigma-Tau Finanzaria S.p.A, of 5,000,000 shares of the Company’s common stock at a price per share of $1.00 (the “Shares”), for gross proceeds of $5,000,000 (the “Offering”). On February 27, 2008, the Company announced that it had entered into a definitive agreement with respect to this Offering. In connection with the Offering, the Company also agreed to issue warrants to purchase an additional 1,000,000 shares of its common stock with an exercise price of $1.60 per share (the “Warrants”).
